-
21.
公开(公告)号:SI1560811T1
公开(公告)日:2007-12-31
申请号:SI200330987
申请日:2003-09-15
Applicant: ABBOTT LAB
Inventor: MADAR DAVID , PEI ZHONGHUA , PIREH DAISY , DJURIC STEVAN W , WIEDEMAN PAUL E , YONG HONG , MICHMERHUIZEN MELISSA J , KOPECKA HANA , LI XIAOFENG , LONGENECKER KENTON , SHAM HING L , STEWART KENT D , SZCZEPANKIEWICZ BRUCE G
IPC: C07D207/00
-
公开(公告)号:DE60315336D1
公开(公告)日:2007-09-13
申请号:DE60315336
申请日:2003-09-15
Applicant: ABBOTT LAB
Inventor: MADAR DAVID , PEI ZHONGHUA , PIREH DAISY , DJURIC STEVAN W , WIEDEMAN PAUL E , YONG HONG , MICHMERHUIZEN MELISSA J , KOPECKA HANA , LI XIAOFENG , LONGENECKER KENTON , SHAM HING L , STEWART KENT D , SZCZEPANKIEWICZ BRUCE G
IPC: C07D207/00 , A61P37/02 , C07D207/16 , C07D207/26 , C07D207/27 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D417/12
Abstract: The present invention relates to compounds of formula I which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases. Or pharmaceutically acceptable salts or prodrugs thereof, wherein X,R,R ,R and R have the definitions given in the description.
-
公开(公告)号:CA2327185A1
公开(公告)日:1999-10-14
申请号:CA2327185
申请日:1999-04-08
Applicant: ABBOTT LAB
Inventor: SCIOTTI RICHARD J , GUBBINS EARL J , LULY JAY R , ZHOU XUN , TU NOAH P , WIEDEMAN PAUL E , WARRIOR USHA , DJURIC STEVAN W , MADAR DAVID J , BA MAUNG NWE Y , BASHA ANWER , WAGENAAR FRANK L
IPC: C07D231/12 , A61K31/415 , A61K31/4155 , A61K31/42 , A61K31/422 , A61K31/425 , A61K31/433 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/445 , A61K31/454 , A61K31/475 , A61P17/00 , A61P17/06 , A61P29/00 , A61P37/02 , A61P37/06 , A61P37/08 , A61P43/00 , C07D231/14 , C07D231/16 , C07D401/04 , C07D401/10 , C07D401/14 , C07D403/10 , C07D403/12 , C07D405/04 , C07D405/10 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/10 , C07D409/14 , C07D413/10 , C07D413/12 , C07D417/10 , C07D417/12 , C07D417/14 , C07D495/04 , C07D231/00 , C07D333/00
Abstract: Compounds having formula (I) are useful for treating diseases that are prevented by or ameliorated with Interleukin-2, Interleukin-4, or Interleukin5 production inhibitors.
-
公开(公告)号:AT148891T
公开(公告)日:1997-02-15
申请号:AT92903749
申请日:1991-12-10
Applicant: ABBOTT LAB
Inventor: WIEDEMAN PAUL E , KAWAI MEGUMI , LULY JAY R , OR YAT SUN , WAGNER ROLF
-
公开(公告)号:CA2045578A1
公开(公告)日:1990-08-01
申请号:CA2045578
申请日:1990-01-16
Applicant: ABBOTT LAB
Inventor: KAWAI MEGUMI , OR YAT S , WIEDEMAN PAUL E , LULY JAY R , MOYER MIKEL P
IPC: C07D327/08 , A61K38/00 , A61P37/00 , C07D211/60 , C07D487/04 , C07D513/04 , C07K5/10 , C07K7/02 , C07K7/06 , C07K14/47 , C07K7/00 , C07K5/00
Abstract: 2045578 9009162 PCTABS00001 Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L-M-Q-T are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.
-
公开(公告)号:CY1110361T1
公开(公告)日:2015-04-29
申请号:CY071101364
申请日:2007-10-23
Applicant: ABBOTT LAB
Inventor: MADAR DAVID , PEI ZHONGHUA , PIREH DAISY , DJURIC STEVAN W , WIEDEMAN PAUL E , YONG HONG , MICHMERHUIZEN MELISSA J , KOPECKA HANA , LI XIAOFENG , LONGENECKER KENTON , SHAM HING L , STEWART KENT D , SZCZEPANKIEWICZ BRUCE G
IPC: C07D207/00 , A61P37/02 , C07D207/16 , C07D207/26 , C07D207/27 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D417/12
Abstract: ΗπαρούσαεφεύρεσησχετίζεταιμεενώσειςτουτύπουΙ οιοποίεςαναστέλλουντηνδιπεπτιδυλικήπεπτιδάση IV (DPP-IV) καιείναιχρήσιμεςγιατηνπρόληψηή τηναγωγήτουδιαβήτη, ειδικάτουδιαβήτητύπουΙΙ, όπωςεπίσηςτηςυπεργλυκαιμίας, τουΣυνδρόμουΧ, τηςυπερινσουλιναιμίας, τηςπαχυσαρκίας, τηςαθηροσκλήρωσης, καιδιαφόρωνανοσορρυθμιστικώννόσων. Ήφαρμακευτικώςαποδεκτάάλαταή προφάρμακααυτών, όπουτα X, R, R1, R2 και R3 έχουντουςορισμούςπουδίνονταιστηνπεριγραφή.
-
公开(公告)号:AR041289A1
公开(公告)日:2005-05-11
申请号:ARP030103370
申请日:2003-09-17
Applicant: ABBOTT LAB
Inventor: FEENSTRA MELISSA , KOPECKA HANA , LI LI , LONGENECKER K , SHAM HING L , STEWART KENT D , MADAR DAVID , PEI ZHONGHUA , PIREH DAISY , DJURIC STEVAN W , WIEDEMAN PAUL E , YONG HONG , SZCZEPANKIEWICZ BRUCE G
IPC: C07D207/16 , A61K31/4025 , A61K31/428 , A61K31/4439 , A61K31/4523 , A61K31/4709 , A61P3/04 , A61P3/10 , A61P5/50 , A61P37/02 , C07D207/26 , C07D207/277 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D417/12 , C07F5/00
Abstract: Compuestos que inhiben la dipeptidil peptidasa IV (DPP-IV) y son de utilidad en la prevención o tratamiento de la diabetes, especialmente la diabetes de tipo II, y también de la hiperglucemia, el Síndrome X, la hiperinsulinemia, la obesidad, laarterosclerosis, y diversas enfermedades inmunomoduladoras. Reivindicación 1: Un compuesto caracterizado porque responde a la fórmula (1), o una sal o prodroga aceptable para uso farmacéutico del mismo, donde X es un miembro seleccionado entre elgrupo que comprende CH2, CHF y CF2; R se selecciona entre el grupo que comprende alquilcarbonilo, arilcarbonilo, ciano, heterociclilcarbonilo, R4R5NC(O)-, B(OR6)2, (1,2,3)-dioxoborolano y 4,4,5,5-tetrametil-(1,2,3)-dioxoborolano; R1 se seleccionaentre el grupo que comprende alcoxialquilo, alquilo, alquilcarbonilo, alquenilo, alquinilo, alenilo, arilaquilo, cicloalquilo, cicloalquilalquilo, ciano, haloalquilo, haloalquenilo, heterociclilalquilo, e hidroxialquilo; R2 y R3 se seleccionan enforma independiente entre el grupo que comprende hidrógeno, alcoxialquilo, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquilalquilo, arilo, arilalquilo, heterociclo, heterociclilalquilo, hidroxialquilo; o R2 y R3 junto con los átomos a loscuales están unidos forman un heterociclo mono o bicíclico seleccionado entre el grupo que comprende 2-indolinilo, 2-indolilo, 3-isoquinolina, 2-piperazina, 2-piperidina, 2-pirrolidina, 2-pirrol, 2-piridina, 2-quinolinilo, 2-tetrahidroquinolinilo, y3-tetrahidroisoquinolinilo, donde dicho heterociclo puede estar sustituido con 0, 1, 2 o 3 sustituyentes seleccionados en forma independiente entre alquenilo, alcoxi, alcoxialquilo, alcoxicarbonilo, alcoxicarbonilalquilo, alquilo, alquilcarbonilo,alquilcarbonilalquilo, alquilcarboniloxi, alquilsulfonilo, alquiltio, alquinilo, arilo, arilalcoxi, arilalquilo, arilcarbonilo, ariloxi, carboxi, carboxialquilo, ciano, cianoalquilo, formilo, halógeno, haloalquilo, hidroxi, hidroxialquilo, mercapto,nitro, fenilo, RaRbN-, RcRdNC(O)-, y RcRdNS(O)2-; R4, R5 y R6 se seleccionan cada uno en forma independiente entre el grupo que comprende hidrógeno, alquilo, y arilalquilo; Ra y Rb se selecciona cada uno en forma independiente entre el grupo quecomprende alquilo, alquilcarbonilo, alcoxicarbonilo, alquilsulfonilo; o Ra y Rb junto con el nitrógeno al cual están unidos forman un anillo seleccionado entre el grupo que comprende piperidina, piperazina y morfolina; y Rc y Rd se seleccionan cadauno en forma independiente entre el grupo que comprende hidrógeno y alquilo.
-
公开(公告)号:CA2497725A1
公开(公告)日:2004-04-01
申请号:CA2497725
申请日:2003-09-15
Applicant: ABBOTT LAB
Inventor: MADAR DAVID , KOPECKA HANA , LI XIAOFENG , FEENSTRA MELISSA J , SZCZEPANKIEWICZ BRUCE G , STEWART KENT D , PEI ZHONGHUA , YONG HONG , WIEDEMAN PAUL E , DJURIC STEVAN W , PIREH DAISY , LONGENECKER KENTON , SHAM HING L
IPC: A61P37/02 , C07D207/16 , C07D207/26 , C07D207/27 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D417/12 , A61K31/401 , A61K31/4439 , A61K31/506
Abstract: The present invention relates to compounds of formula I which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia , Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases. Or pharmaceutically acceptable salts or prodrugs thereof, wherein X,R,R1,R2 and R3 have the definitions given in the description.
-
公开(公告)号:BR0010555A
公开(公告)日:2003-09-23
申请号:BR0010555
申请日:2000-10-10
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GIRANDA VINCENT L , KEMPF DALE J , STOLL VINCENT S , SUN MINGHUA , ZHAO CHEN , GU YU GUI , HANESSIAN STEPHEN , WANG GARY T , KRUEGER ALLAN C , CHEN HUI-JU , CHEN YUANWEI , DEGOEY DAVID A , FLOSI WILLIAM J , GRAMPOVNIK DAVID J , KATI WARREN M , KENNEDY APRIL L , KLEIN LARRY L , LIN ZHEN , MADIGAN DAROLD L , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , TU NOAH P , WAGENAAR FRANK L , WANG SHELDON , WIEDEMAN PAUL E , XU YIBO , YEUNG MING C , BAYRAKDARIAN MALKEN , LUO XUEHONG
IPC: C07D401/12 , A61K31/357 , A61K31/40 , A61K31/401 , A61K31/4025 , A61K31/405 , A61K31/415 , A61K31/4155 , A61K31/4178 , A61K31/42 , A61K31/422 , A61K31/425 , A61K31/427 , A61K31/4439 , A61K31/5377 , A61K31/66 , A61K31/662 , A61P31/00 , A61P31/12 , A61P31/16 , A61P43/00 , C07D20060101 , C07D207/00 , C07D207/12 , C07D207/16 , C07D207/26 , C07D207/32 , C07D207/327 , C07D207/38 , C07D207/46 , C07D303/16 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D407/06 , C07D407/12 , C07D409/06 , C07D413/04 , C07D413/06 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/40 , C07F9/572
-
公开(公告)号:DE69124705D1
公开(公告)日:1997-03-27
申请号:DE69124705
申请日:1991-12-10
Applicant: ABBOTT LAB
Inventor: WIEDEMAN PAUL E , KAWAI MEGUMI , LULY JAY , OR YAT , WAGNER ROLF
-
-
-
-
-
-
-
-
-